“Speed to Exit”: How to Get an IPO Closed in Record Time
By

We’ve all heard the phrase “Speed to Market.”  But how many have heard “Speed to Exit?”  Probably not many, since I just created it.  It really is a phrase that should be part of every CFO’s vocabulary.  Speed to exit is the driving force to get a liquidity event, like…Read More

Read More
Fundraising Choices in Life Sciences: What, When & Why?
By

This article is the second in a two-part series about fundraising strategies for life science companies. In our last article, A Menu of Financing Alternatives for Life Science Companies, we looked at the continuum of choices available to life science companies who are actively engaged in fundraising to power up…Read More

Read More
A Menu of Financing Alternatives for Life Science Companies
By

This article is the first in a two-part series about fundraising strategies for life science companies. A Menu of Financing Alternatives for Life Science Companies Fundraising Choices in Life Sciences: What, When & Why? Life science companies, from emerging to evolved, therapeutics to diagnostics, solo or partnered, are constantly fundraising….Read More

Read More
Equity vs. Debt Financing : When to Use Either (or Both)
By

At FLG Partners, we work with many high growth clients and one of our clear areas of expertise is fundraising. Companies today have several options to finance growth at their companies; cash flow, debt and equity. Established players can often use the cash flow they generate from sales of their…Read More

Read More